Helix Acquisition Corp. II | 10-K: FY2024 Annual Report
BridgeBio Spinout to Go Public in SPAC Deal With Helix Acquisition Corp. II
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics
Express News | Trading Halt: Halt Status Updated at 8:15:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Helix Acquisition Corp II - Combined Company to Be Listed on Nasdaq Under Ticker Bbot
Express News | Helix Acquisition Corp II - Total Proceeds Expected to Be $450 Million From Deal
Express News | BridgeBio Oncology Therapeutics (Bbot) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of Ras and Pi3KΑ-Targeting Medicines
Express News | Trading Halt: Halted at 7:19:25 A.m. ET - Trading Halt: Halt News Pending
Helix Acquisition Corp. II | 10-Q: Q3 2024 Earnings Report
Helix Acquisition Corp. II | 10-Q: Quarterly report
Helix Acquisition II Closes Initial Public Offering With $184M in Gross Proceeds >HLXB
Helix Acquisition Corp. II Announces Closing of $184 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares
Express News | Helix Acquisition Corp II IPO Shares Open For Trade
Express News | Hearing Helix Acquisition Corp II IPO Indicating $10/Share On 347,455 Shares; IPO Priced At $10/Share On 16M Shares
Express News | Trading Halt: Halt Status Updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation
Helix Acquisition Corp. II Expects the Offering to Be Consummated on Feb 13 >HLXB
Helix Acquisition Corp. II Shares Will Be Listed on the Nasdaq Global Market and Trade Under the Ticker Symbol HLXB >HLXB
Helix Acquisition Corp. II Priced Its Upsized Initial Public Offering of 16M Class A Ordinary Shrs at $10.00 Per Shr >HLXB
Helix Acquisition Corp. II Announces Pricing of Upsized $160 Million Initial Public Offering